Nocturnal Hypertension Control Improved With Bedtime Antihypertensive Dosing
WEDNESDAY, July 16, 2025 -- Bedtime dosing with antihypertensive medication yields better nocturnal blood pressure control and improved circadian rhythm, according to a study published online July 9 in JAMA Network Open.
Runyu Ye, Ph.D., from Sichuan University in Chengdu, China, and colleagues compared the effects of morning versus bedtime antihypertensive medication administration on nocturnal blood pressure reduction and circadian rhythm in a randomized trial conducted at 15 hospitals involving patients with hypertension. Patients without prior antihypertensive treatment or who had discontinued antihypertensive agents for two weeks were randomly assigned to the morning (6 a.m. to 10 a.m.) or bedtime (6 p.m. to 10 p.m.) dosing groups (352 and 368, respectively); all patients received a single pill containing olmesartan (20 mg) and amlodipine (5 mg) daily for 12 weeks.
The researchers found that patients in the bedtime dosing group showed significantly greater reductions in nighttime systolic blood pressure and nighttime diastolic blood pressure compared with patients in the morning dosing group (between-group differences, −3.0 and −1.4 mm Hg); better nocturnal systolic blood pressure control was seen (79.0 versus 69.8 percent) and circadian rhythm was improved. There was no difference in the incidence of nocturnal hypotension.
"These findings support the potential advantages of bedtime administration and offer new evidence to guide future research on antihypertensive chronotherapy," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.